Fierce Pharma Biopharma News & Insights
WEBFierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 20 Pharmaceutical Companies by Revenue 2021 | FiercePharma
WEBThe pharma industry quickly took center stage when COVID-19 caught the world off guard early last year. As 2020 progressed, drugmakers battled the coronavirus on one hand and on the other ...
Pharma | Fierce Pharma
WEB1 day ago · J&J cuts 231 at NJ headquarters; Bayer lops off 57 more at US HQ. J&J is laying off 231 employees in New Jersey and Bayer is cutting 57 positions in the state. J&J’s cuts are at its corporate HQ ...
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of ...
WEBSep 28, 2018 · The loss of Cialis comes during a major time of transformation for Lilly. During its second-quarter earnings report in July, the company announced that it will spin off its animal health unit ...
The top 20 pharma companies by 2021 revenue
WEBOf the world’s top 20 pharmas ranked by 2021 revenues, 12 had at least 10% growth, including five that saw their sales boom at least 40%. No company pulled in more revenue from COVID products ...
The top 15 blockbuster patent expirations coming this decade
WEBJul 12, 2021 · Looking out over the next decade, some of the biggest drugs in the industry will tumble off the patent cliff, putting pharma giants in the hot seat as investors clamor for their next blockbuster.
The top 10 most profitable pharma companies in 2021
WEBJun 14, 2022 · The six largest drugmakers by 2021 revenue—J&J, Pfizer, Roche, AbbVie, Novartis and Merck & Co.—all made the top profit list but in quite a different order.
Big Pharma Companies Ranked by Revenue 2022 - Fierce Pharma
WEBBy Kevin Dunleavy Apr 18, 2023 12:00am. Johnson & Johnson Pfizer revenue growth Roche. Pfizer made biopharma industry history in 2022, becoming the first company to ring up $100 billion in revenue ...
The top 10 generic drug makers by 2021 revenue - Fierce Pharma
WEBMany producers of generic drugs have struggled to achieve growth in recent years due to pricing pressures. But there are promising signs that the industry is ready for an uptick, and they were ...
Bayer's Farxiga rival Kerendia scores long-awaited kidney and …
WEBJul 9, 2021 · RELATED: Bayer looks for pharma growth in 2021 as new drugs start to take shape About 40% of Type 2 diabetes patients in the U.S. will ultimately develop chronic kidney disease, Bayer figures, and ...